Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 70

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 70
---
 Stock. Any preferred stock
issued may contain provisions allowing those shares to be converted into shares of Common Stock, which could dilute the value of our Common
Stock to current stockholders and could adversely affect the market price, if any, of our Common Stock. The preferred stock could be utilized,
under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company. Although we have
no present intention to issue any shares of our authorized preferred stock, there can be no assurance that we will not do so in the future.

Provisions in our Articles of Incorporation, our Bylaws, and Nevada law might discourage, delay or prevent a change in control of our company or changes in our management and, therefore, depress the trading price of our Common Stock.

Provisions of our Articles of Incorporation, our
Bylaws, and Nevada law may have the effect of deterring unsolicited takeovers or delaying or preventing a change in control of our company
or changes in our management, including transactions in which our stockholders might otherwise receive a premium for their shares over
then current market prices. In addition, these provisions may limit the ability of stockholders to approve transactions that they may
deem to be in their best interests. These provisions include:

| · | the inability of stockholders to call special meetings; |

| · | the “business combinations” and “control share acquisitions” provisions of Nevada                                                           
 law, to the extent applicable, could discourage attempts to acquire our stockholders stock even on terms above the prevailing market price; 
 and                                                                                                                                         |

| · | the ability of our board of directors to designate the terms of and issue new series of preferred stock                                
 without stockholder approval, which could include the right to approve an acquisition or other change in our control or could be used  
 to institute a rights plan, also known as a poison pill, that would dilute the stock ownership of a potential hostile acquirer, likely 
 preventing acquisitions that have not been approved by our board of directors.                                                         |

The existence of the forgoing provisions and anti-takeover
measures could limit the price that investors might be willing to pay in the future for shares of our Common Stock. They could also deter
potential acquirers of our company, thereby reducing the likelihood that you could receive a premium for your Common Stock in an acquisition.

<div align='center'>34

Cautionary Note
Regarding Forward-Looking Statements</div>

This prospectus contains “forward-looking